This content is from: Premium
These Health Care Funds Had a Rough Quarter
Perceptive, Casdin, and others started the year with losses after posting explosive results in 2020.
.png)
Several hedge funds in what has been one of the hottest sectors suffered a setback in the first quarter.At least four funds that specialize in life sciences or biopharma stocks posted losses for the three-month period, even as the S&P 500 index rose 6.2 percent, including dividends reinvested.For many of
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.